These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2040397)

  • 21. Cisapride in the treatment of gastro-oesophageal reflux disease.
    Robertson CS; Evans DF; Ledingham SJ; Atkinson M
    Aliment Pharmacol Ther; 1993 Apr; 7(2):181-90. PubMed ID: 8485271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pattern of acid reflux in patients with reflux esophagitis 'resistant' to H2-receptor antagonists.
    Bianchi Porro G; Pace F; Sangaletti O
    Scand J Gastroenterol; 1990 Aug; 25(8):810-4. PubMed ID: 1976270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Famotidine in the management of acid-reflux oesophagitis: a multicentre study.
    Bovero E; Poletti M; Iaquinto G; Giardulo N; Zambelli A; Pisano G; Cheli R
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():145-8. PubMed ID: 2083926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of cisapride on relapse of reflux oesophagitis, healed with an antisecretory drug.
    Tytgat GN; Anker Hansen OJ; Carling L; de Groot GH; Geldof H; Glise H; Efskind P; Elsborg L; Karvonen AL; Ohlin B
    Scand J Gastroenterol; 1992; 27(3):175-83. PubMed ID: 1502478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of pathophysiology, severity, and cost on the medical management of gastroesophageal reflux disease.
    Reynolds JC
    Am J Health Syst Pharm; 1996 Nov; 53(22 Suppl 3):S5-12. PubMed ID: 8931825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastroesophageal reflux: diagnosis and management.
    Richter JE
    Hosp Pract (Off Ed); 1992 Jan; 27(1):59-66. PubMed ID: 1346142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of cisapride on symptoms and healing of gastro-oesophageal reflux disease: a review.
    Richter JE
    Scand J Gastroenterol Suppl; 1989; 165():19-27; discussion 27-8. PubMed ID: 2690321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.
    Fiorucci S; Santucci L; Morelli A
    Am J Gastroenterol; 1990 Nov; 85(11):1458-62. PubMed ID: 2239873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cisapride versus ranitidine in the treatment of reflux esophagitis.
    Janisch HD; Hüttemann W; Bouzo MH
    Hepatogastroenterology; 1988 Jun; 35(3):125-7. PubMed ID: 3042576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The medical management of reflux esophagitis. Role of antacids and acid inhibition.
    Sontag SJ
    Gastroenterol Clin North Am; 1990 Sep; 19(3):683-712. PubMed ID: 1977703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of bronchial asthma associated with reflux esophagitis, whose peak expiratory flow rate improved with omeprazole and cisapride].
    Fujimori K; Suzuki E; Arakawa M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Nov; 32(11):1088-93. PubMed ID: 7815763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is a proton pump inhibitor necessary for the treatment of lower-grade reflux esophagitis?
    Soga T; Matsuura M; Kodama Y; Fujita T; Sekimoto I; Nishimura K; Yoshida S; Kutsumi H; Fujimoto S
    J Gastroenterol; 1999 Aug; 34(4):435-40. PubMed ID: 10452673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of esophageal motility abnormalities in severe reflux esophagitis].
    Xu JY; Xie XP; Hou XH
    Zhonghua Nei Ke Za Zhi; 2005 May; 44(5):353-5. PubMed ID: 16009005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride.
    Galmiche JP; Barthelemy P; Hamelin B
    Aliment Pharmacol Ther; 1997 Aug; 11(4):765-73. PubMed ID: 9305487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a proton pump inhibitor, AG-1749 (lansoprazole), on reflux esophagitis and experimental ulcers in rats.
    Inatomi N; Nagaya H; Takami K; Shino A; Satoh H
    Jpn J Pharmacol; 1991 Apr; 55(4):437-51. PubMed ID: 1886289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible involvement of host defense mechanism in the suppression of rat acute reflux esophagitis by the particular histamine H2 receptor antagonist lafutidine.
    Nakano M; Ajioka H; Abe M; Kiniwa M
    Pharmacology; 2012; 90(3-4):205-11. PubMed ID: 23038658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [24-hour esophageal pH-metry in the evaluation of gastroesophageal reflux pathology].
    Accorsini M; Averbene C; Caiulo VA; Ughi C; Ceccarelli M
    Minerva Pediatr; 1992 May; 44(5):185-8. PubMed ID: 1620071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cisapride versus ranitidine in reflux esophagitis].
    Janisch HD
    Z Gastroenterol; 1990 Apr; 28 Suppl 1():67-9; discussion 77-8. PubMed ID: 2192508
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative study of nizatidine and famotidine for maintenance therapy of erosive esophagitis.
    Hamamoto N; Hashimoto T; Adachi K; Hirakawa K; Ishihara S; Inoue H; Taniura H; Niigaki M; Sato S; Kushiyama Y; Suetsugu H; Miyake T; Kinoshita Y
    J Gastroenterol Hepatol; 2005 Feb; 20(2):281-6. PubMed ID: 15683433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lansoprazole versus famotidine in symptomatic reflux esophagitis: a randomized, multicenter study.
    Umeda N; Miki K; Hoshino E
    J Clin Gastroenterol; 1995; 20 Suppl 1():S17-23. PubMed ID: 7673609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.